Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval

被引:35
|
作者
Ogilvie, Gina S. [1 ,2 ,8 ]
Smith, Laurie W. [3 ]
van Niekerk, Dirk [3 ]
Khurshed, Fareeza [3 ]
Pedersen, Heather N. [1 ]
Taylor, Darlene [4 ]
Thomson, Katharine
Greene, Sandra B. [5 ]
Babich, Suzanne M. [6 ]
Franco, Eduardo L. [7 ]
Coldman, Andrew J. [1 ,4 ]
机构
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[2] Womens Hlth Res Inst, Vancouver, BC, Canada
[3] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[4] British Columbia Ctr Dis Control, Vancouver, BC, Canada
[5] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA
[6] Indiana Univ Purdue Univ, Richard M Fairbanks Sch Publ Hlth, Indianapolis, IN 46202 USA
[7] McGill Univ, Montreal, PQ, Canada
[8] BC Womens Hosp & Hlth Ctr, Room H203G,4500 Oak St, Vancouver, BC V6H 3N1, Canada
基金
加拿大健康研究院;
关键词
Cervical cancer; Human papillomavirus; Theory of planned behaviour; Screening programs; RANDOMIZED CONTROLLED-TRIAL; FOLLOW-UP; HPV; CYTOLOGY; BELIEFS; PREVENTION; MANAGEMENT; KNOWLEDGE; ATTITUDES; DNA;
D O I
10.1186/s12889-016-2865-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: High-risk HPV DNA testing has been proposed as a primary tool for cervical cancer screening (HPV-CCS) as an alternative to the Papanicolaou cytology-method. This study describes factors associated with women's intentions to attend cervical cancer screening if high-risk HPV DNA testing (HPV-CCS) was implemented as a primary screening tool, and if screening were conducted every 4 years starting after age 25. Methods: This online survey was designed using the Theory of Planned Behaviour to assess factors that impact women's intentions to attend HPV-CCS among women aged 25-69 upon exit of the HPV FOCAL trial. Univariate and regression analyses were performed to compare the demographic, sexual history, and smoking characteristics between women willing and unwilling to screen, and scales for intention to attend HPV-CCS. A qualitative analysis was performed by compiling and coding the comments section of the survey. Results: Of the 981 women who completed the survey in full, only 51.4 % responded that they intended to attend HPV-CCS with a delayed start age and extended screening interval. Women who intended to screen were more likely to have higher education (AOR 0.59, 95 % CI [0.37, 0.93]), while both positive attitudes (AOR 1.26, 95 % CI [1.23, 1.30]) and perceived behavior control (AOR 1.06, 95 % CI [1.02, 1.10]) were significant predictors of intention to screen. Among women who provided comments in the survey, a large number of women expressed fears about not being checked more than every 4 years, but 12 % stated that these fears may be alleviated by having more information. Conclusions: Acceptability of increased screening intervals and starting age could be improved through enhanced education of benefits. Program planners should consider measures to assess and improve women's knowledge, attitudes and beliefs prior to the implementation of new screening programs to avoid unintended consequences.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Human papillomavirus testing for primary cervical cancer screening
    Meijer, CJLM
    Rozendaal, L
    vanderLinden, JC
    Helmerhorst, TJM
    Voorhorst, FJ
    Walboomers, JMM
    [J]. NEW DEVELOPMENTS IN CERVICAL CANCER SCREENING AND PREVENTION, 1997, : 338 - 347
  • [42] Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotesting
    Rendle, Katharine A.
    Schiffman, Mark
    Cheung, Li C.
    Kinney, Walter K.
    Fetterman, Barbara
    Poitras, Nancy E.
    Lorey, Thomas
    Castle, Philip E.
    [J]. PREVENTIVE MEDICINE, 2018, 109 : 44 - 50
  • [43] PREDICTORS OF WOMEN'S INTENTIONS TO RECEIVE CERVICAL CANCER SCREENING WITH PRIMARY HPV TESTING
    Ogilvie, G.
    Smith, L.
    van Niekerk, D.
    Khurshed, F.
    Greene, S.
    Hobbs, S.
    Coldman, A.
    Franco, E.
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2013, 89 : A44 - A45
  • [44] Human papillomavirus testing as a screening tool for cervical cancer
    Koss, LG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (19): : 2525 - 2525
  • [45] Human papillomavirus testing for primary cervical cancer screening
    Grce, Magdalena
    Davies, Philip
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2008, 8 (05) : 599 - 605
  • [46] Role of human papillomavirus genotyping in cervical cancer screening
    Andujar-Sanchez, Miguel
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2023, 41 (05): : 259 - 261
  • [47] Cervical cancer screening in the time of the human papillomavirus vaccine
    Sheinfeld, Gorin S.
    Franco, R.
    Hajiani, F.
    Westhoff, C.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (02) : 358 - 358
  • [48] Human papillomavirus vaccines versus cervical cancer screening
    Stantey, M.
    [J]. CLINICAL ONCOLOGY, 2008, 20 (06) : 388 - 394
  • [49] The application of human papillomavirus testing to cervical cancer screening
    Lee, HP
    Seo, SS
    [J]. YONSEI MEDICAL JOURNAL, 2002, 43 (06) : 763 - 768
  • [50] Human papillomavirus testing for primary cervical cancer screening
    Carolyn D. Runowicz
    Stephanie Garozzo
    [J]. Current Oncology Reports, 2008, 10